A revolutionary new test for the early detection of testicular cancer—the most common cancer among young men—is now available in the UK. Developed by Cambridge-based EDX Medical, the non-invasive “TC100”…
Transforming Healthcare with Quake’s Real-Time UHF RFID Optimization for Patients, Pathology, Blood Banks, Pharmaceuticals, and Hospital Logistics Quake Global Unveils QIAM: A Fully Integrated AI-Powered RFID Solution for Epic EMR…
Health Catalyst Launches Ignite Spark™ — Purpose-Built Data and Analytics Solution for Community Health Systems Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology for healthcare…
Large-Scale Studies Find Effective Strategy to Improve Antibiotic Use in Hospitals Two extensive multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine,…
Study Finds K Health’s AI Recommendations Match Doctors’ in Accuracy K Health, a leading AI-driven primary care platform, recently revealed exciting results from a novel study demonstrating that its AI-powered…
U of A Study: Openwater’s Open-LIFU 2.0 Reduces Depression Symptoms in Under 2 Hours Openwater, a leader in open-source medical technology, has announced breakthrough results from a study conducted by…
Viz.ai Wins 2025 Edison Award™ for Machine Learning Innovation for Third Year Viz.ai, a leader in artificial intelligence (AI)-powered disease detection and intelligent care coordination, has announced its recognition as…
UCI Health Enhances Web Experience with aha! Platform Acquisition Abundant Health Acquisition (aha!) is proud to announce the launch of UCI Health’s newly redesigned website, built on aha!’s Health Experience…
FDA Grants Paige Breakthrough Designation for AI Cancer Detection Across Sites Paige, a leader in next-generation AI technology, has announced that the U.S. Food and Drug Administration (FDA) has granted…
Heart Rhythm Case Reports Publishes First Use of AI-Guided ECG Mapping for Left Bundle Branch Area Pacing Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, has announced the…
Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints Sinaptica Therapeutics, Inc., a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced…
Click Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments Click Therapeutics, Inc. (“Click”), a pioneer in the development of prescription medical treatments, has unveiled a…